Trial intelligence / Profile preview

H5N1 Vaccine Booster in Healthy Adults

NCT00240968Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Oct 2005
Primary completion
Jul 2006
Countries
1
01

Overview

A Phase 2 trial of Inactivated Influenza A/H5N1 Vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2005; status: completed.

02

Drugs

Inactivated Influenza A/H5N1 Vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00240968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call